A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Expand the sub-collections menu.
7 documents on 1 page
 
close this section of the libraryLeufkens, Hubert G
Open this document and view its content
Title: Differences in the Availability of Medicines for Chronic and Acute Conditions in the Public and Private Sectors of Developing Countries
Subjects: Medicine Access and Rational Use > Pricing
Medicine Access and Rational Use > Supply Management
Author: Cameron, Alexandra; Ewen, Margaret; Laing, Richard; Leufkens, Hubert G; Mantel-Teeuwisse, Aukje K.; Roubos, Ilse
Year: 2011 Pages: 24
Publishers:
Regions: Global
Open this document and view its content
Title: Global Strategies to Reduce the Price of Antiretroviral Medicines: Evidence from Transactional Databases
Subjects: Medicine Access and Rational Use > Pricing
Author: Fox, Matthew P; Kaplan, Warren; King, Alexis C; Lawrence, Danielle A; Leufkens, Hubert G; Waning, Brenda
Year: 2007 Pages: 9
Publishers:
Regions: Global
Open this document and view its content
Title: Impact of External Price Referencing on Medicine Prices – A Price Comparison Among 14 European Countries - Southern Med Review Vol 5 Issue 2 December 2012
Subjects: Medicine Access and Rational Use > Pricing
Author: de Joncheere, Kees; Laing, Richard; Leopold, Christine; Leufkens, Hubert G; Mantel-Teeuwisse, Aukje K.; Seyfang, Leonhard; Vogler, Sabine
Year: 2012 Pages: 8
Publishers:
Related links:
Regions: Europe (EURO)
Open this document and view its content
Title: Is it Justified to let Medicines Fly Without a Black Box? - Southern Med Review Vol 3 Issue 2 Oct 2010
Subjects: Medicine Information and Evidence for Policy > Information and Publications
Quality and Safety: Medicines > Safety and Efficacy
Author: Leufkens, Hubert G
Year: 2010 Pages: 1
Regions: Global
Open this document and view its content
Title: "Rare Essentials": Drugs for Rare Diseases as Essential Medicines. «Rares et essentiels» : considérons les médicaments destinés au traitement des maladies rares comme des médicaments essentiels. «Medicamentos esenciales raros»: los fármacos contra enfermedades raras como medicamentos esenciales.
Subjects: Medicine Access and Rational Use > Selection
Author: Leufkens, Hubert G; Stolk, Pieter; Willemen, Marjolein JC
Year: 2006 Pages: 7
Publishers:
Regions: Global
Open this document and view its content
Title: Regulatory Scientific Advice in Drug Development: Does Company Size Make a Difference?
Subjects: Quality and Safety: Medicines > Regulatory Support
Author: Gispen-De Wied, Christine C.; Hoes, Arno W.; Leufkens, Hubert G; Mantel-Teeuwisse, Aukje K.; Putzeist, Michelle
Year: 2010 Pages: 8
Regions: Europe (EURO)
Countries: Netherlands
Open this document and view its content
Title: Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?
Subjects: Medicine Information and Evidence for Policy > Medicines Policy
Medicine Access and Rational Use > Financing
Medicine Access and Rational Use > Pricing
Author: Cameron, Alexandra; Laing, Richard; Leufkens, Hubert G; Mantel-Teeuwisse, Aukje K.
Year: 2012 Pages: 10
Regions: Global
 

Last updated: May 3, 2013